Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action for its Investigational Drug Ridinilazole During IDWeek 2021

NEXT STORY
Todos Medical Announces Positive Observational Trial Results for Oral Antiviral 3CL Protease (MPro) Inhibitor Tollovir®
PREV STORY
New Data Highlighting Itch Reduction with Topical Roflumilast in Multiple Dermatologic Conditions Presented at European Academy of Dermatology and Venereology Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nivano Physicians, Inc. and Apollo Managed Care Together Supporting Provider Networks

Integration of Apollo Managed Care Guidelines into Nivano Physicians’ workflow will place the required ...

author_avatar
NASDAQ Market News

Enzymatica AB: Bulletin from extraordinary general meeting in Enzymatica AB (publ)

Today on 19 December 2016 at Enzymatica's extraordinary general meeting in Lund, the meeting ...

author_avatar
NASDAQ Market News

TPP Healthcare Successfully Implements Legacy Healthcare into China

NEW YORK, Oct. 26, 2017 (GLOBE NEWSWIRE) -- TPP Healthcare, a strategic advisory firm ...

author_avatar
NASDAQ Market News